川崎病休克综合征诊治进展
Progress in the Diagnosis and Treatment of Kawasaki Disease Shock Syndrome
摘要: 川崎病(Kawasaki disease, KD)是一种常见于儿童的免疫性血管炎症，是儿童后天获得性心脏病的主要原因。川崎病休克综合征(Kawasaki disease shock syndrome, KDSS)是川崎病的一种少见且严重亚型，休克发生可能与高炎症反应、毛细血管持续渗漏、心肌功能障碍、对超抗原过度反应相关。KDSS常发生在疾病早期阶段，临床症状不典型，常合并有多系统损害，容易误诊。因此，需提高临床医生对KDSS的认识，早期诊断并及时治疗以控制其发生发展。本文就KDSS诊治进展进行综述。
Abstract: Kawasaki disease (KD) is an immune vascular inflammation that is common in children and is the main cause of acquired heart disease in children. Kawasaki disease shock syndrome (KDSS) is a rare and severe subtype of Kawasaki disease. The occurrence of shock may be related to high inflamma-tory response, continuous capillary leakage, myocardial dysfunction, and overreaction to superan-tigens. KDSS often occurs in the early stage of the disease, with atypical clinical symptoms, often combined with multi-system damage, and easy to be misdiagnosed. Therefore, it is necessary to improve clinicians’ understanding of KDSS, in order to make early diagnosis and timely treatment to control its occurrence and development. This article reviews the progress in the diagnosis and treatment of KDSS.
文章引用：陈俊男, 易岂建. 川崎病休克综合征诊治进展[J]. 临床医学进展, 2023, 13(5): 7574-7580. https://doi.org/10.12677/ACM.2023.1351058

参考文献

[1] McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
[2] Kanegaye, J.T., Wilder, M.S., Molkara, D., et al. (2009) Recognition of a Kawasaki Disease Shock Syndrome. Pediatrics, 123, e783-e789. [Google Scholar] [CrossRef] [PubMed]
[3] Park, W.Y., Lee, S.Y., Kim, G.B., et al. (2021) Clinical Aspects for Differential Diagnosis of Kawasaki Disease Shock Syndrome: A Case Con-trol Study. BMC Pediatrics, 21, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[4] Gamez-Gonzalez, L.B., Moribe-Quintero, I., Cisneros-Castolo, M., et al. (2018) Kawasaki Disease Shock Syndrome: Unique and Severe Subtype of Kawasaki Disease. Pediatrics In-ternational, 60, 781-790. [Google Scholar] [CrossRef] [PubMed]
[5] Liang, Y.C., Chang, C.H., Lin, M.T., Kao, F.Y., Huang, S.K. and Wu, M.H. (2020) Shock and Unresponsiveness to Repeated Courses of Intravenous Immunoglobulin in Kawasaki Disease: A Nationwide Database Study. Pediatric Research, 87, 961-966. [Google Scholar] [CrossRef] [PubMed]
[6] 徐梅先, 刘刚, 曹利静, 石晓娜, 孙慧, 李君娥. 儿童川崎病休克综合征与脓毒性休克早期主要临床特征的对比研究[J]. 中国全科医学, 2020, 23(30): 3812-3816, 3828.
[7] Zhang, M.M., Shi, L., Li, X.H., Lin, Y. and Liu, Y. (2017) Clinical Analysis of Kawasaki Disease Shock Syndrome. Chinese Medical Journal (England), 130, 2891-2892. [Google Scholar] [CrossRef] [PubMed]
[8] Qiu, H., Li, C., He, Y., et al. (2019) Association between Left Ventricular Ejection Fraction and Kawasaki Disease Shock Syndrome. Cardiology in the Young, 29, 178-184. [Google Scholar] [CrossRef] 
[9] 李薇玢, 刘琮, 谭卫群, 等. 川崎病休克综合征的实验室指标及超声特点分析[J]. 中华实用儿科临床杂志, 2019, 34(19): 1476-1479.
[10] Chang, Y.H., Lin, C.Y., Liu, L.H., Huang, F.H. and Cheng, Y.J. (2022) Acute Appendicitis as the Initial Presentation of Kawasaki Disease Shock Syn-drome in Children. Children (Basel), 9, 1819. [Google Scholar] [CrossRef] [PubMed]
[11] Taddio, A., Rossi, E.D., Monasta, L., et al. (2017) Describing Kawasaki Shock Syndrome: Results from a Retrospective Study and Litera-ture Review. Clinical Rheumatology, 36, 223-228. [Google Scholar] [CrossRef] [PubMed]
[12] Li, Y., Zheng, Q., Zou, L., et al. (2019) Kawasaki Disease Shock Syndrome: Clinical Characteristics and Possible Use of IL-6, IL-10 and IFN-γ as Biomarkers for Early Recognition. Pediatric Rheumatology Online Journal, 17, 1. [Google Scholar] [CrossRef] [PubMed]
[13] 赵小佩, 肖婷婷, 张永为. 川崎病休克综合征临床特征分析[J]. 临床儿科杂志, 2019, 37(4): 245-249.
[14] Schuster, J.E., Palac, H.L., Innocentini, N., Rowley, A.H., Young, L.T. and Shulman, S.T. (2017) Hyponatremia Is a Feature of Kawasaki Disease Shock Syndrome: A Case-Control Study. Journal of the Pediatric Infectious Diseases Society, 6, 386-388. [Google Scholar] [CrossRef] [PubMed]
[15] 仇慧仙, 薛超超, 陈其, 等. 川崎病休克综合征的临床特点及危险因素分析[J]. 中华危重症医学杂志(电子版), 2015(4): 230-234.
[16] 单鸣凤, 梅小丽, 周凯, 等. 儿童川崎病休克综合征的临床特点及相关因素[J]. 中华实用儿科临床杂志, 2018, 33(9): 673-678.
[17] 沈林云, 蒋琼俏, 管敏昌, 汪官富, 汤卫红. 外周血白细胞介素-6和白细胞介素-10水平联合检测在早期识别川崎病休克综合征中的应用价值[J]. 中国卫生检验杂志, 2019, 29(17): 2128-2130.
[18] 中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会. 川崎病冠状动脉病变的临床处理建议(2020年修订版) [J]. 中华儿科杂志, 2020, 58(9): 718-724.
[19] 马乐, 俞海国. 川崎病休克综合征的临床特征及血清白细胞介素-6表达水平分析[J]. 中国小儿急救医学, 2021, 28(8): 679-683.
[20] Singer, M., Deutsch-man, C.S., Seymour, C.W., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
[21] Power, A., Runeckles, K., Manlhiot, C., Dragulescu, A., Guerguerian, A.M. and McCrindle, B.W. (2021) Kawasaki Disease Shock Syndrome versus Septic Shock: Early Differentiating Features despite Overlapping Clinical Profiles. The Journal of Pediatrics, 231, 162-167. [Google Scholar] [CrossRef] [PubMed]
[22] García-Pavón, S., Yamazaki-Nakashimada, M.A., Báez, M., Bor-jas-Aguilar, K.L. and Murata, C. (2017) Kawasaki Disease Complicated with Macrophage Activation Syndrome: A Sys-tematic Review. Journal of Pediatric Hematology/Oncology, 39, 445-451. [Google Scholar] [CrossRef] 
[23] Pilania, R.K., Arora, K., Gupta, A., Vignesh, P., Suri, D. and Singh, S. (2021) A 5-Year-Old Boy with Kawasaki Disease Shock Syndrome, Myocarditis and Macrophage Activa-tion Syndrome. Journal of Paediatrics and Child Health, 57, 1312-1315. [Google Scholar] [CrossRef] [PubMed]
[24] Ravelli, A., Minoia, F., Davì, S., et al. (2016) 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Annals of Rheumatic Diseases, 75, 481-489.
[25] Suzuki, J., Abe, K., Matsui, T., et al. (2021) Kawasaki Dis-ease Shock Syndrome in Japan and Comparison with Multisystem Inflammatory Syndrome in Children in European Countries. Frontiers in Pediatrics, 9, Article ID: 625456. [Google Scholar] [CrossRef] [PubMed]
[26] Lamrani, L., Manlhiot, C., Elias, M.D., et al. (2021) Kawasaki Dis-ease Shock Syndrome vs Classical Kawasaki Disease: A Meta-Analysis and Comparison with SARS-CoV-2 Multisys-tem Inflammatory Syndrome. The Canadian Journal of Cardiology, 37, 1619-1628. [Google Scholar] [CrossRef] [PubMed]
[27] Consiglio, C.R., Cotugno, N., Sardh, F., et al. (2020) The Immu-nology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell, 183, 968-981.e7. [Google Scholar] [CrossRef] [PubMed]
[28] Merckx, J., Cooke, S., El Tal, T., et al. (2022) Predictors of Severe Illness in Children with Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection: A Multicentre Cohort Study. CMAJ, 194, E513-E523. [Google Scholar] [CrossRef] [PubMed]
[29] Gámez-González, L.B., Ramírez-López, M.J., Colmenero-Rascón, M. and Yamazaki-Nakashimada, M.A. (2022) Kawasaki Disease Shock Syndrome in the COVID-19 Pandemic. Cardiology in the Young, 32, 506-507. [Google Scholar] [CrossRef] 
[30] Burns, J.C., Hoshino, S. and Kobayashi, T. (2018) Kawasaki Disease: An Essential Comparison of Coronary Artery Aneurysm Criteria. The Lancet Child & Adolescent Health, 2, 840-841. [Google Scholar] [CrossRef] 

为你推荐